On 7/31/24, MacroGenics Inc (NASDAQ: MGNX) stock suffered a major decline of -28.4%, closing at $3.76. Moreover, exceptionally high trading volume at 377% of normal accompanied the decline. Relative to the market the stock has been extremely weak over the last nine months and has declined -29.5% during the last week.
Current PriceTarget Research Rating
With future capital returns forecasted to exceed the cost of capital, MGNX is expected to continue to be a major Value Builder.
MacroGenics has a current Value Trend Rating of F (Lowest Rating). This rating combines consistent signals from two proprietary PTR measures of a stock’s attractiveness. MacroGenics has a poor Appreciation Score of 17 and a very low Power Rating of 9, resulting in the Lowest Value Trend Rating.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment